Skip to main content

Table 1 Characteristics of patients and samples involved in the study

From: Growth factor independence underpins a paroxysmal, aggressive Wnt5aHigh/EphA2Low phenotype in glioblastoma stem cells, conducive to experimental combinatorial therapy

ID SAMPLE

Gender

Clinical Age

Clinical IDH1

EGFRvIII

TERT PROMOTER

Clinical Pathology

Patient #1

M

79

WT

NO

C228T

GBM

Patient #2

M

76

WT

NO

C228T

GBM

Patient #8

M

76

WT

YES

C228T

GBM

Patient #9

M

79

WT

YES

C228T

GBM

Patient #14

F

80

WT

NO

C228T

GBM

Patient #11

M

71

WT

NO

C228T

GBM

Patient #6

F

52

WT

NO

C250T

GBM

Patient #12

M

43

WT

NO

C228T

GBM

Patient #7

F

44

WT

NO

C228T

GBM -GLIOSARCOMA

Patient #13

M

42

WT

NO

C228T

GBM

Patient #16

M

70

WT

NO

C228T

GBM

Patient #17

F

72

WT

NO

C250T

GBM

Patient #3

M

62

WT

NO

C228T

GBM

Patient #5

F

56

WT

NO

C228T

GBM

Patient #10

F

73

WT

YES

C228T

GBM

Patient #15

M

62

WT

NO

C228T

GBM